| REVIEW ARTICLE |
|
| Year : 2001 | Volume
: 2
| Issue : 2 | Page : 57-62 |
|
|
Hypertension in renal transplant recipients
Omar Abboud
Consultant Nephrologist, Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar
Correspondence Address:
Omar Abboud
Hamad Medical Corporation, P.O. Box 3050, Doha
Qatar
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
The prevalence of hypertension in patients with end-stage renal disease ranges between 10 and 100%[1]. It occurs in renal transplant recipients in 40 – 75%[3],[4]. Factors contributing to post-transplant hypertension include immunosuppressive therapy: corticosteroids and calcineurin inhibitors; causes related to the graft: chronic graft dysfunction, genetic, renal artery stenosis, recurrence of the original disease and factors related to the native kidneys. Investigation of post-transplant hypertension should be directed to these possible underlying factors. Treatment considerations will depend on the presence or absence of underlying factors and should observe interaction between hypotensive medications and immunosuppressive drugs.
|
|
|
|
| [PDF]* |
|
 |
|
